Filtern
Quelle
  • ariva.de
  • fool.de
  • ntg24.de
  • wallstreet-online.de
Markt
  • Amerika
  • Asien
  • Australien
  • Europa
Index
  • DAX
  • MDAX
  • NASDAQ
  • NYSE
  • SDAX
  • TecDAX
Anlageklasse
  • Aktien
  • Anleihen
  • CFD
  • Derivate
  • ETF
  • Fonds
  • Rohstoffe
  • Währungen
Nachrichtentyp
  • Ad-hoc Mitteilungen
  • Analysen
  • Chartanalysen
  • Empfehlungen
  • IPO Nachrichten
  • Marktberichte
  • Nachrichten
Thema
  • Biotechnologie
  • Finanzdienstleistungen
  • Immobilien
  • Internet
  • Lifestyle
  • Nanotechnologie
  • Politik
  • Recht
  • Sonstige Technologie
  • Sonstiges
  • Sport
  • Steuern
  • Telekommunikation
  • Termine
  • Unternehmen
  • Wissenswertes
Filter zurücksetzen

Nachrichten Seite 1.004

26. Februar 2026 08:00 Neutral
The J.M. Smucker Co. Announces Fiscal 2026 Third Quarter Results
[weiter]
Quelle: ariva.de
26. Februar 2026 08:00 Neutral
The J.M. Smucker Co. Appoints Two New Independent Directors
[weiter]
Quelle: ariva.de
26. Februar 2026 08:00 Positiv
Corbion announces strong full-year 2025 results with +26.7% organic Adjusted EBITDA growth, +63.3% EPS growth, and ¤90.8 million in FCF; announces special dividend
Corbion, the Amsterdam-listed sustainable food-ingredients company that champions preservation through application of science, today publishes its results for the year ending 31 December 2025. Key highlights ...[weiter]
Quelle: ariva.de
26. Februar 2026 08:00 Neutral
MSC Income Fund Announces Regular Quarterly Dividend and Supplemental Dividend
[weiter]
Quelle: ariva.de
26. Februar 2026 08:00 Neutral
Warner Bros. Discovery Reports Fourth Quarter and Full Year 2025 Results
[weiter]
Quelle: ariva.de
26. Februar 2026 08:00 Positiv
Syensqo fourth quarter and full year 2025 results
Press releaseCommuniqué de pressePersbericht Syensqo fourth quarter and full year 2025 results Full year free cash flow of ¤356 million, above prior outlook; Pro forma full year underlying EBITDA of …
Quelle: ariva.de
26. Februar 2026 08:00 Positiv
Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics
Partnership with leading nuclear medicine specialist enables advancing pipeline of wholly-owned Radio-DARPin therapeutics for imaging and therapeutic radio-isotopes, including Actinium-225 (225Ac) ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 26, 2026 (GLOBE …
Quelle: ariva.de
26. Februar 2026 08:00 Neutral
Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs …
Quelle: ariva.de
26. Februar 2026 08:00 Neutral
Westhaven Gold Announces Participation in Red Cloud's Pre-PDAC Mining Showcase
[weiter]
Quelle: ariva.de
26. Februar 2026 08:00 Neutral
Graphite One Announces Appointment of Lucille Carter as Vice President, Community Relations and Online Marketing Update
[weiter]
Quelle: ariva.de
26. Februar 2026 08:00 Positiv
Clariant delivers third year of strong EBITDA margin improvement ? EBITDA margin before exceptional items up 180 basis points versus prior year to 17.8 %
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR FOURTH QUARTER / FULL YEAR | 2025 Q4 2025 sales increased by 1 % in local currencies1to CHF 1.028 billion due to …
Quelle: ariva.de
26. Februar 2026 08:00 Negativ
Silber: Edelmetall startet wieder durch
Nachdem der Silberpreis bei 121,64 US-Dollar Ende Januar seinen Höchststand erreicht hatte, wurde der Preis massiv abwärts geprügelt, in der Spitze ging es bis Anfang Februar auf 64,10 US-Dollar abwärts. …
Quelle: wallstreet-online.de
26. Februar 2026 08:00 Neutral
dsm-firmenich cancels its shares following completion of its ¤1.08 billion share repurchase program
Press Release dsm-firmenich cancels its shares following completion of its ¤1.08 billion share repurchase program [weiter]
Quelle: ariva.de
26. Februar 2026 08:00 Neutral
Vistra Reports Fourth Quarter and Full-Year 2025 Results
[weiter]
Quelle: ariva.de
26. Februar 2026 08:00 Positiv
Idorsia reports strong 2025 results with QUVIVIQ sales more than doubling ? further sales growth ahead with multiple pipeline catalysts in 2026
Ad hoc announcement pursuant to Art. 53 LR Idorsia delivers on its upgraded 2025 guidance , with strong QUVIVIQ sales growth, disciplined investment, and a significantly improved bottom line.Focused ...[weiter]
Quelle: ariva.de
15.046 bis 15.060 von 55.267 Ergebnissen